BioAffinity Technologies Inc (NASDAQ:BIAF) currently has a daily average trading volume of 9.81M but it saw 2062626 shares traded in last market. With a market cap of 3.88M USD, the company’s current market price of $0.21 came rising about 0.90 while comparing to the previous closing price of $0.21. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.99 and as low as $0.16.
Taking a look at 20-day trading activity of BioAffinity Technologies Inc (BIAF) gives us an average price of $0.4669, while its current price level is -92.88% below from 52-week high level whereas it is 29.84% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4478 while that of 200 days or SMA-200 reads an average of $1.1540. A closer look into the stock’s movement over the week reveals that its volatility is standing at 23.42% during that period while stretching the period over a month that decreases to 17.00%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 30.82 which implies that the stock is in neutral territory.
Over the week, BIAF’s stock price is moving -54.72% down while it is -69.60% when we observe its performance for the past one month. Year-to-date it is -76.62% down and over the past year, the stock is showing a downside performance of -89.82%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.16 while estimate for next year EPS is -0.45. In next quarter, company is expected to be making quarterly sales of $1.21M as analysts are expecting the sales for current fiscal year at $6.05M and seeing the company making $7.25M in sales next year. Moreover, analysts are in estimates of $2.11M for current-quarter revenue.
Currently, BioAffinity Technologies Inc’s total number of outstanding shares is 15.58M with 27.77% of that held by the insiders while 2.96% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -265.19% and return on equity (ROE) at -242.44%. Stock’s beta reads 3.12. Stock has a price to book (P/B) ratio of 1.27 while price to sale or P/S ratio amounts to 0.42. Its return on asset (ROA) is -122.70% on average.
